Benzinga | May 6, 2021 04:56PM EDT

Homology Medicines Q1 EPS $(0.02) Up From $(0.78) YoY, Sales $29.30M Up From $588.00K YoY

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.02) per share. This is a 97.44 percent increase over losses of $(0.78) per share from the same period last year. The company reported $29.30 million in sales this quarter. This is a 4.88K percent increase over sales of $588.00 thousand the same period last year.